Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DKS Co. Ltd. (4461.T)
Kyoto, JP
Headquartered in Kyoto, Japan, DKS Co. Ltd. is a global producer and purveyor of a diverse range of industrial chemicals and surfactants, serving numerous industries worldwide. The company’s operations are organized into six distinct segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electronic Device Materials, and Life Sciences. Within its Surfactants division, DKS develops various types such as nonionic, anionic, cationic, polymerizable, and amphoteric compounds, in addition to specialized surfactant blends. The Amenity Materials segment features products like sucrose fatty acid esters, sodium carboxymethyl celluloses, cellulose nanofibers and other polymers, polyvinyl pyrrolidone, polyacrylamide and polyacrylate, and industrial deodorizers. Its Polyurethane Materials offerings include polyether polyols, urethane prepolymers, and comprehensive urethane systems. For Functional Materials, DKS manufactures radiation-curable monomers and oligomers, waterborne polyurethanes, flame retardants, and amide-based lubricants. The Electronic Device Materials group supplies ionic liquids, ion-conductive polymers, ceramic/metal injection molding components, conductive pastes for electronic applications, injection molding pellets, and advanced inorganic materials. Furthermore, the Life Sciences segment crafts health and dietary supplements, notably an I. Japonica-Bombyx Fungus product and Sudachin, a distinct citrus peel extract powder. Founded in 1909, the firm was formerly known as Dai-ichi Kogyo Seiyaku Co., Ltd. before rebranding to DKS Co. Ltd. in 2013.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.71% | +2.83% | +0.89% | -19.29% | +19.16% | +11.55% | +201.16% | +377.39% | +152.92% | +434.12% | +553.24% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+13.2% ★ Q1'26: +19.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+124.5% ★ Q1'26: +185.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.2% ★ Q1'26: +13.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+11.8% ★ Q1'26: +14.6% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+6.3% Q1'26: +9.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.19× Q1'26: 1.86× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
56.96B
est: 57.00B (-0.1%)
|
59.57B
est: 60.40B (-1.4%)
|
61.46B
est: 62.20B (-1.2%)
|
59.14B
est: 59.55B (-0.7%)
|
62.67B
est: 61.99B (+1.1%)
|
65.08B
est: 64.25B (+1.3%)
|
63.12B
est: 66.77B (-5.5%)
|
73.26B
est: 72.00B (+1.7%)
|
81.00B
81.00B – 81.00B
+12.5% YoY
|
87.00B
87.00B – 87.00B
+7.4% YoY
|
92.00B
92.00B – 92.00B
+5.7% YoY
|
| EBITDA |
7.53B
est: 5.97B (+26.1%)
|
7.01B
est: 6.32B (+10.8%)
|
6.49B
est: 6.51B (-0.4%)
|
7.46B
est: 6.24B (+19.6%)
|
7.98B
est: 6.49B (+23.0%)
|
3.83B
est: 6.73B (-43.0%)
|
5.85B
est: 6.99B (-16.3%)
|
8.68B
est: 7.54B (+15.1%)
|
8.48B
8.48B – 8.48B
+12.5% YoY
|
9.11B
9.11B – 9.11B
+7.4% YoY
|
9.63B
9.63B – 9.63B
+5.7% YoY
|
| EBIT |
5.05B
est: 2.98B (+69.7%)
|
4.34B
est: 3.16B (+37.6%)
|
3.57B
est: 3.25B (+9.8%)
|
4.00B
est: 3.11B (+28.5%)
|
4.40B
est: 3.24B (+36.0%)
|
462.00M
est: 3.36B (-86.2%)
|
2.64B
est: 3.49B (-24.4%)
|
5.46B
est: 3.76B (+45.0%)
|
4.23B
4.23B – 4.23B
+12.5% YoY
|
4.54B
4.54B – 4.54B
+7.4% YoY
|
4.81B
4.81B – 4.81B
+5.7% YoY
|
| Net Income |
3.35B
est: 3.11B (+7.7%)
|
2.58B
est: 2.58B (0.0%)
|
2.01B
est: 2.22B (-9.4%)
|
2.56B
est: 2.41B (+6.2%)
|
2.49B
est: 3.01B (-17.2%)
|
-407.00M
est: -200.10M (-103.4%)
|
1.17B
est: 2.26B (-48.1%)
|
2.59B
est: 3.10B (-16.6%)
|
5.19B
5.19B – 5.19B
+67.4% YoY
|
5.87B
5.87B – 5.87B
+13.0% YoY
|
6.59B
6.59B – 6.59B
+12.3% YoY
|
| SGA |
10.01B
est: 8.33B (+20.1%)
|
11.10B
est: 8.83B (+25.7%)
|
11.31B
est: 9.09B (+24.4%)
|
7.42B
est: 8.70B (-14.7%)
|
7.73B
est: 9.06B (-14.7%)
|
11.77B
est: 9.39B (+25.3%)
|
7.90B
est: 9.76B (-19.0%)
|
12.89B
est: 10.52B (+22.4%)
|
11.84B
11.84B – 11.84B
+12.5% YoY
|
12.72B
12.72B – 12.72B
+7.4% YoY
|
13.45B
13.45B – 13.45B
+5.7% YoY
|
| EPS |
330.21
est: 325.00 (+1.6%)
|
254.09
est: 269.65 (-5.8%)
|
198.09
est: 232.10 (-14.7%)
|
251.92
est: 252.10 (-0.1%)
|
244.77
est: 314.20 (-22.1%)
|
-41.80
est: -20.90 (-100.0%)
|
122.73
est: 236.05 (-48.0%)
|
269.99
est: 323.70 (-16.6%)
|
541.90
541.90 – 541.90
+67.4% YoY
|
612.60
612.60 – 612.60
+13.0% YoY
|
688.00
688.00 – 688.00
+12.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Small-Cap Equity Factor ETF ISCF | 0.15% | 990.8K | 0.24% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.08% | 292.2K | 0.58% |
| 3 | State Street SPDR S&P International Small Cap ETF GWX | 0.06% | 562.8K | 0.40% |
| 4 | WisdomTree Japan Equity UCITS ETF - USD Hedged Acc DXJA.L | 0.03% | 278.2K | 0.48% |
| 5 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.03% | 372.1K | 0.45% |
| 6 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.03% | 316.9K | 0.45% |
| 7 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.03% | 343.5K | 0.45% |
| 8 | WisdomTree Japan Equity UCITS ETF - USD Acc DXJZ.L | 0.03% | 278.2K | 0.40% |
| 9 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.03% | 278.2K | 0.48% |
| 10 | Schwab International Small-Cap Equity ETF SCHC | 0.03% | 1.34M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideto Misawa | Senior Executive Officer & Executive GM of Sales Headquarters | — | male |
| Isao Nishiguchi | Senior Executive Officer & Senior Executive GM Life Sciences Headquarters | — | — |
| Jiro Owan | Executive Officer and Executive GM Electronics & IT Business Division | — | — |
| Kazuto Morishima | Senior Executive Officer, Senior Executive GM of DKS Group Management Div. Admin. Headquarters | — | — |
| Kisou Watanabe | Executive Officer & Executive GM of Yokkaichi Plant & Production Headquarters | — | — |
| Koji Shimizu | Senior Executive Officer & Senior Executive GM Production Headquarters | — | male |
| Mami Sakamoto | Senior Executive Officer, Senior Executive GM Administration Headquarters & Director | — | female |
| Masahiro Kitao | Senior Executive Officer, Senior Executive GM of Business Headquarters & Director | — | — |
| Naoki Yamaji | President, COO, CEO & Director | — | male |
| Shinji Shimizu | Representative Senior MD, CFO & Representative Director | — | male |
| Takuya Kuze | Executive Officer & GM of Shiga Plant - Production Headquarters | — | — |
| Yoshiyuki Mori | Senior Executive Officer & Senior Executive GM od Production Technology R&D Division | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4461.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
